NephroGenex To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum

NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present a corporate overview of the Company and meet with investors at the 13th annual Bio Investor Forum at the Palace Hotel in San Francisco.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC